Teriparatide is a hormone or hormone-signaling compound.
Also known as teriparatide
Current picks · Nov 14, 2026
Up to three of the lowest effective prices per exact product among vendors that passed the trust floor, were in stock and checked within 72 hours, and have a COA on file for that product and strength tested within 12 months. Affiliate relationships never affect picks or their order.
No offer meets every pick rule today. The exact-product comparisons below still list every recorded price.
Same format. Same amount.
0 of 0 exact products have at least one pick. Vendor counts reflect the current price observations.
Vendor profiles and catalog information are still available below.
What it is
Teriparatide can cause cancer according to state or federal government labeling requirements. The listed molecular formula is C181H291N55O51S2. PepGrades separately preserves the catalog category because a chemical identity record does not establish a use, outcome, or product quality.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
5 registered studies were found under this name in the current review. Each study still needs to be checked for the exact compound identity, population, endpoints, and results.
Search indexed research for this compound ↗Market context
Teriparatide is commonly sold or discussed for hormone signaling, fertility, sexual health, or related endocrine research. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Vendor directory
Grades describe the vendor record overall, not a test of every product. Lowest prices are effective single-package prices across formats; open a comparison for the exact product.
No vendor has a current Teriparatide offer on record.
1 tracked vendor lists Teriparatide without a current offer: Atomik Labz (Not graded).
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.